Taiwanese Dermatological Association consensus for the management of atopic dermatitis

C.-Y. Chu; C.-H. Lee; I.-H. Shih; H.-C. Chen; P.-H. Huang; Chia-Yu Yang; W.-J. Wang; Y.-J. Chen; H.-M. Sheu; W.-M. Wang; W.-R. Lee; Y.-H. Lo; Y.-S. Dai; L.-F. Wang; T.-F. Tsai; C.-H. Yang

doi:10.1016/j.dsi.2015.06.004

Taiwanese Dermatological Association consensus for the management of atopic dermatitis

C.-Y. Chu, C.-H. Lee, I.-H. Shih, H.-C. Chen, P.-H. Huang, Chia-Yu Yang, W.-J. Wang, Y.-J. Chen, H.-M. Sheu, W.-M. Wang, W.-R. Lee, Y.-H. Lo, Y.-S. Dai, L.-F. Wang, T.-F. Tsai, C.-H. Yang

Department of Microbiology and Immunology

Research output: Contribution to journal › Journal Article › peer-review

Abstract

Background/Objective: This report describes the 2014 consensus of the Taiwanese Dermatological Association (TDA) regarding the treatment of atopic dermatitis (AD). The TDA consensus is distributed to practices throughout Taiwan to provide recommendations for therapeutic approaches for AD patients to improve their quality of life. Methods: The information in the consensus was agreed upon by a panel of national experts at TDA AD consensus meetings held on March 16, May 4, and June 29, 2014. The consensus was in part based on the 2013 Asia-Pacific AD guidelines and the guidelines of the American Academy of Dermatology, with modification to reflect the clinical practice in Taiwan. Results: The amendments were drafted after scientific discussions focused on the quality of evidence, risk, and benefits; all the consensus contents were voted on by the participating dermatologists, with approval by at least 75% for inclusion. Conclusion: The consensus provides a comprehensive overview of treatment for AD, with some local and cultural considerations for practitioners in Taiwan, especially the use of wet dressings/wraps, systemic immunomodulatory agents, and complementary therapies.

Original language	American English
Pages (from-to)	220-230
Journal	Dermatologica Sinica
Volume	33
Issue number	4
DOIs	https://doi.org/10.1016/j.dsi.2015.06.004
State	Published - 2015

Keywords

Atopic dermatitis
Consensus
Treatment

Access to Document

10.1016/j.dsi.2015.06.004

Cite this

Chu, C.-Y., Lee, C.-H., Shih, I.-H., Chen, H.-C., Huang, P.-H., Yang, C.-Y., Wang, W.-J., Chen, Y.-J., Sheu, H.-M., Wang, W.-M., Lee, W.-R., Lo, Y.-H., Dai, Y.-S., Wang, L.-F., Tsai, T.-F., & Yang, C.-H. (2015). Taiwanese Dermatological Association consensus for the management of atopic dermatitis. Dermatologica Sinica, 33(4), 220-230. https://doi.org/10.1016/j.dsi.2015.06.004

@article{d775ffae33ec4df09723e7cdf2368279,

title = "Taiwanese Dermatological Association consensus for the management of atopic dermatitis",

abstract = "Background/Objective: This report describes the 2014 consensus of the Taiwanese Dermatological Association (TDA) regarding the treatment of atopic dermatitis (AD). The TDA consensus is distributed to practices throughout Taiwan to provide recommendations for therapeutic approaches for AD patients to improve their quality of life. Methods: The information in the consensus was agreed upon by a panel of national experts at TDA AD consensus meetings held on March 16, May 4, and June 29, 2014. The consensus was in part based on the 2013 Asia-Pacific AD guidelines and the guidelines of the American Academy of Dermatology, with modification to reflect the clinical practice in Taiwan. Results: The amendments were drafted after scientific discussions focused on the quality of evidence, risk, and benefits; all the consensus contents were voted on by the participating dermatologists, with approval by at least 75% for inclusion. Conclusion: The consensus provides a comprehensive overview of treatment for AD, with some local and cultural considerations for practitioners in Taiwan, especially the use of wet dressings/wraps, systemic immunomodulatory agents, and complementary therapies.",

keywords = "Atopic dermatitis, Consensus, Treatment",

author = "C.-Y. Chu and C.-H. Lee and I.-H. Shih and H.-C. Chen and P.-H. Huang and Chia-Yu Yang and W.-J. Wang and Y.-J. Chen and H.-M. Sheu and W.-M. Wang and W.-R. Lee and Y.-H. Lo and Y.-S. Dai and L.-F. Wang and T.-F. Tsai and C.-H. Yang",

year = "2015",

doi = "10.1016/j.dsi.2015.06.004",

language = "American English",

volume = "33",

pages = "220--230",

journal = "Dermatologica Sinica",

issn = "1027-8117",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - Taiwanese Dermatological Association consensus for the management of atopic dermatitis

AU - Chu, C.-Y.

AU - Lee, C.-H.

AU - Shih, I.-H.

AU - Chen, H.-C.

AU - Huang, P.-H.

AU - Yang, Chia-Yu

AU - Wang, W.-J.

AU - Chen, Y.-J.

AU - Sheu, H.-M.

AU - Wang, W.-M.

AU - Lee, W.-R.

AU - Lo, Y.-H.

AU - Dai, Y.-S.

AU - Wang, L.-F.

AU - Tsai, T.-F.

AU - Yang, C.-H.

PY - 2015

Y1 - 2015

N2 - Background/Objective: This report describes the 2014 consensus of the Taiwanese Dermatological Association (TDA) regarding the treatment of atopic dermatitis (AD). The TDA consensus is distributed to practices throughout Taiwan to provide recommendations for therapeutic approaches for AD patients to improve their quality of life. Methods: The information in the consensus was agreed upon by a panel of national experts at TDA AD consensus meetings held on March 16, May 4, and June 29, 2014. The consensus was in part based on the 2013 Asia-Pacific AD guidelines and the guidelines of the American Academy of Dermatology, with modification to reflect the clinical practice in Taiwan. Results: The amendments were drafted after scientific discussions focused on the quality of evidence, risk, and benefits; all the consensus contents were voted on by the participating dermatologists, with approval by at least 75% for inclusion. Conclusion: The consensus provides a comprehensive overview of treatment for AD, with some local and cultural considerations for practitioners in Taiwan, especially the use of wet dressings/wraps, systemic immunomodulatory agents, and complementary therapies.

AB - Background/Objective: This report describes the 2014 consensus of the Taiwanese Dermatological Association (TDA) regarding the treatment of atopic dermatitis (AD). The TDA consensus is distributed to practices throughout Taiwan to provide recommendations for therapeutic approaches for AD patients to improve their quality of life. Methods: The information in the consensus was agreed upon by a panel of national experts at TDA AD consensus meetings held on March 16, May 4, and June 29, 2014. The consensus was in part based on the 2013 Asia-Pacific AD guidelines and the guidelines of the American Academy of Dermatology, with modification to reflect the clinical practice in Taiwan. Results: The amendments were drafted after scientific discussions focused on the quality of evidence, risk, and benefits; all the consensus contents were voted on by the participating dermatologists, with approval by at least 75% for inclusion. Conclusion: The consensus provides a comprehensive overview of treatment for AD, with some local and cultural considerations for practitioners in Taiwan, especially the use of wet dressings/wraps, systemic immunomodulatory agents, and complementary therapies.

KW - Atopic dermatitis

KW - Consensus

KW - Treatment

U2 - 10.1016/j.dsi.2015.06.004

DO - 10.1016/j.dsi.2015.06.004

M3 - Journal Article

SN - 1027-8117

VL - 33

SP - 220

EP - 230

JO - Dermatologica Sinica

JF - Dermatologica Sinica

IS - 4

ER -

Taiwanese Dermatological Association consensus for the management of atopic dermatitis

Abstract

Keywords

Access to Document

Fingerprint

Cite this